BRIEF published on 01/21/2025 at 07:03, 1 year 8 months ago DocMorris Reports 6.7% Growth in 2024 with Strong Rx Revenue Surge 2024 Financial Results DocMorris Growth Rx Revenue Increase TeleClinic Performance German Market Trends
BRIEF published on 01/21/2025 at 07:03, 1 year 8 months ago DocMorris annonce une croissance de 6,7 % en 2024 avec une forte augmentation des revenus des médicaments sur ordonnance Résultats Financiers 2024 Croissance De DocMorris Augmentation Des Revenus Des Médicaments Sur Ordonnance Performances De La TéléClinique Tendances Du Marché Allemand
PRESS RELEASE published on 01/21/2025 at 06:58, 1 year 8 months ago DocMorris grows 6.7 per cent in 2024 and accelerates Rx growth in the fourth quarter DocMorris grows 6.7% in 2024 with increased Rx sales, OTC revenues and TeleClinic profits. Achieved revenue target and positive cash position. Outlook confirmed for 2024 Revenue Growth DocMorris Rx Sales TeleClinic OTC Revenues
BRIEF published on 10/15/2024 at 07:03, 1 year 11 months ago DocMorris Accelerates Prescription Medicine Growth Revenue Growth Telehealth DocMorris AG Prescription Medicine Logistics Closure
BRIEF published on 10/15/2024 at 07:03, 1 year 11 months ago DocMorris accélère la croissance des médicaments sur ordonnance Croissance Des Revenus Télésanté DocMorris AG Médicaments Sur Ordonnance Fermeture Logistique
PRESS RELEASE published on 10/15/2024 at 06:58, 1 year 11 months ago DocMorris accelerates Rx growth DocMorris accelerates Rx growth with a 12.2% revenue increase in Q3, new CTO appointed, and logistics site closure in Germany. Strong growth in e-prescriptions and customer base E-prescriptions DocMorris CTO Appointment Rx Growth Logistics Site Closure
BRIEF published on 08/20/2024 at 07:03, 2 years 1 month ago DocMorris Enhances Prescription Business and Boosts New Rx Customer Investment 2024 Outlook E-prescriptions DocMorris Prescription Business TeleClinic
BRIEF published on 08/20/2024 at 07:03, 2 years 1 month ago DocMorris améliore son activité de prescription et stimule les investissements de ses nouveaux clients en matière de prescription Perspectives 2024 Ordonnances Électroniques Doc Morris Entreprise De Prescription TéléClinique
PRESS RELEASE published on 08/20/2024 at 06:58, 2 years 1 month ago DocMorris grows in the prescription business and invests incrementally in new Rx customers DocMorris reports growth in prescription business and increased investments in new Rx customers. Break-even reached, outlook for 2024 adjusted due to e-prescription transition Financial Results E-prescriptions New Customers DocMorris Prescription Business
BRIEF published on 07/11/2024 at 07:03, 2 years 2 months ago DocMorris Reports Significant eRx Growth in Q2 2024 Revenue Increase Market Expansion DocMorris ERx Growth
Published on 10/05/2026 at 22:30, 2 hours 44 minutes ago EV Nickel Announces Formation of Wholly Owned Subsidiary to Advance Nickel Bioleaching Technology and Canadian Nickel Supply Chain
Published on 10/05/2026 at 14:45, 10 hours 29 minutes ago NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives
Published on 10/05/2026 at 14:30, 10 hours 44 minutes ago Hillcrest and Equipmake Expand Partnership Talks to Include Commercial Licensing of ZVS Technology
Published on 10/05/2026 at 14:30, 10 hours 44 minutes ago Solitario CEO to Present at John Tumazos Very Independent Research, LLC
Published on 10/05/2026 at 14:00, 11 hours 14 minutes ago Tectonic Metals Appoints Eduard Epshtein as CFO, Bolstering Executive Team for Next Stage of Growth
Published on 10/05/2026 at 22:25, 2 hours 49 minutes ago LumApps Named a Leader in 2026 Gartner® Magic Quadrant™ for Intranet Packaged Solutions
Published on 10/05/2026 at 22:05, 3 hours 9 minutes ago AMPERA SUBMITS COMPREHENSIVE ENGAGEMENT PLAN TO THE U.S. NUCLEAR REGULATORY COMMISSION
Published on 10/05/2026 at 21:10, 4 hours 4 minutes ago Shelly Group Board of Directors considers EUR 70.00 offer price fair and supports Schneider Electric’s voluntary public tender offer
Published on 10/05/2026 at 21:05, 4 hours 9 minutes ago EQS-Adhoc: Shelly Group SE: Board of Directors with positive opinion on the registered voluntary public tender offer by Schneider Electric SE
Published on 10/05/2026 at 20:15, 4 hours 59 minutes ago EQS-Adhoc: United Internet AG participates in capital increase against contributions in kind at 1&1 AG
Published on 10/05/2026 at 22:12, 3 hours 2 minutes ago AXA - Elimination of the dilutive impact of Shareplan 2026
Published on 10/05/2026 at 22:12, 3 hours 2 minutes ago AXA - Elimination de l'effet dilutif de l'opération Shareplan 2026
Published on 10/05/2026 at 18:13, 7 hours 1 minute ago Disclosure of shares outstanding and voting rights - 05.10.2026
Published on 10/05/2026 at 18:13, 7 hours 1 minute ago Déclaration nombre d'actions et droits de vote - 05.10.2026
Published on 10/05/2026 at 18:00, 7 hours 14 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 30 septembre 2026
